Physicians' Academy for Cardiovascular Education

Addressing the unmet needs in LDL-c lowering; what can we expect?

10' education - Nov. 4, 2022 - Prof. John Kastelein, MD, PhD - Amsterdam, The Netherlands

Video navigation menu

  • How well are we treating our ASCVD patients? 1:04
  • How can we improve this? 1:53
  • How can we improve in practice? 3:28
  • How does CETP fit in? 6:37
  • Conclusions 13:37


Show transcript

Educational information

This lecture by John Kastelein was part of the EBAC-accredited symposium "A decade of innovation, guidelines. and paradigm shifts in LDL-c management" held during the ESC congress 2022.


Prof. John Kastelein, MD, PhD – Emeritus Professor of Medicine at the Department of Vascular Medicine at the Academic Medical Center (AMC) of the University of Amsterdam, The Netherlands.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by unrestricted educational grants from Daiichi-Sankyo, New Amsterdam Pharma, Novartis, Sanofi & Ultragenyx.

View slides of this presentation Listen to the podcast

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: